Elite Healthcare Alliance
Protect yourself. Pre-exposure prophylaxis (or PrEP) is when people at very high risk for HIV take HIV medicines daily to lower their chances of getting infected. A combination of two HIV medicines (tenofovir and emtricitabine), sold under the name Truvada® (pronounced tru vá duh), is approved for daily use as PrEP to help prevent an HIV-negative person from getting HIV from a sexual or injection-drug-using partner who’s positive. Studies have shown that PrEP is highly effective for preventing HIV if it is used as prescribed. PrEP is much less effective when it is not taken consistently.
It is important to remember that HIV can affect anyone: men, women, gay, straight, young, or old. For example, according to the Centers for Disease Control and Prevention (CDC), women account for 1 of every 4 new HIV infections. And 1 of every 3 new infections is the result of sex between a man and a woman.
The human immunodeficiency virus (HIV) and the disease it causes, acquired immune deficiency syndrome (AIDS), are seldom in headlines anymore. That's because, in recent years, the news about HIV and AIDS has been mostly encouraging in the United States. The number of people getting infected with HIV has not increased. The death rate from AIDS has dropped. And, thanks to new types of medicines, HIV infection can now be treated and controlled.
If you have any questions regarding your risks or do not know where to turn for answers, call us or schedule an appointment today.